Table 2. Summary for modeling outlier sites in six cancer types.
| Cancer Type | S3 | p | α | S4 | S5 |
|---|---|---|---|---|---|
| Lung* | -- | 0.0 | -- | -- | -- |
| Breast | 0.12 | 8.75E-04 (8.21E-04) | 88.6 (32.0) | 0.102 (0.068) | 0.004 (0.004) |
| CNS | 0.02 | 2.73E-04 (1.09E-04) | 295.1 (57.0) | 0.448 (0.173) | 0.026 (0.015) |
| Kidney | 0.03 | 3.03E-05 (2.98E-05) | 304.1 (108.0) | 0.067 (0.056) | 0.005 (0.006) |
| Upper-AD tract | 0.47 | 0.002 (0.001) | 48.9 (10.7) | 0.174 (0.078) | 0.005 (0.003) |
| Large intestine | 1.03 | 0.009 (0.001) | 51.6 (1.4) | 0.998 (0.087) | 0.026 (0.003) |
Note – For each cancer type, p stands for the proportion of highly mutable sites, with mutation rate being α-fold of the average. S3 gives the expected number without mutable outliers (P=0). S4 and S5 denote the expected number with the best (p, α) pairs with the standard deviation in parentheses. For lung cancer, S2 and S3 do not fit the outlier model (Table 2—source data 1); therefore, we set P=0.